Tao J - Search Results

1

Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.

Yuan W, Zhou R, Wang J, Han J, Yang X, Yu H, Lu H, Zhang X, Li P, Tao J, Wei J, Lu Q, Yang H, Gu M. Yuan W, et al. Among authors: tao j. Mol Oncol. 2019 Jul;13(7):1559-1576. doi: 10.1002/1878-0261.12523. Epub 2019 Jun 9. Mol Oncol. 2019. PMID: 31131537 Free PMC article.

2

A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo.

Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang ZD, Tong N, Wang JF, Song NH, Zhang W, Hua LX, Wu HF. Xu B, et al. Among authors: tao j. Prostate. 2010 Apr 1;70(5):467-72. doi: 10.1002/pros.21080. Prostate. 2010. PMID: 19902466

3

VEGFA +936C>T polymorphism and cancer risk: a meta-analysis.

Xu B, Li JM, Tong N, Tao J, Li PC, Song NH, Zhang W, Wu HF, Feng NH, Hua LX. Xu B, et al. Among authors: tao j. Cancer Genet Cytogenet. 2010 Apr 1;198(1):7-14. doi: 10.1016/j.cancergencyto.2009.11.007. Cancer Genet Cytogenet. 2010. PMID: 20303008

4

A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression.

Xu B, Wang J, Tong N, Mi Y, Min Z, Tao J, Li P, Cheng G, Li J, Wang M, Tang J, Song N, Zhang Z, Zhang W, Wu H, Hua L, Feng N. Xu B, et al. Among authors: tao j. Prostate. 2010 Jul 1;70(10):1146-52. doi: 10.1002/pros.21149. Prostate. 2010. PMID: 20333697

5

p53 codon 72 increased biochemical recurrence risk after radical prostatectomy in a southern Chinese population.

Xu B, Mi YY, Min ZC, Cheng G, Tong N, Tao J, Li PC, Wang ML, Tang JL, Zhang ZD, Song NH, Zhang W, Wu HF, Feng NH, Hua LX. Xu B, et al. Among authors: tao j. Urol Int. 2010;85(4):401-5. doi: 10.1159/000315991. Epub 2010 Jul 20. Urol Int. 2010. PMID: 20664183

6

Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese.

Xu B, Xu Z, Cheng G, Min ZC, Mi Y, Zhang ZZ, Tao J, Li PC, Wang ML, Tang JL, Zhang ZD, Zhang W, Wu HF, Feng NH, Hua LX. Xu B, et al. Among authors: tao j. Cancer Genet Cytogenet. 2010 Oct 15;202(2):76-81. doi: 10.1016/j.cancergencyto.2010.02.014. Cancer Genet Cytogenet. 2010. PMID: 20875869

7

IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls.

Xu B, Niu XB, Wang ZD, Cheng W, Tong N, Mi YY, Min ZC, Tao J, Li PC, Zhang W, Wu HF, Zhang ZD, Wang ZJ, Hua LX, Feng NH, Wang XR. Xu B, et al. Among authors: tao j. Mol Biol Rep. 2011 Apr;38(4):2589-96. doi: 10.1007/s11033-010-0399-1. Epub 2010 Nov 23. Mol Biol Rep. 2011. PMID: 21104146

8

miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.

Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N, Wang Z, Hua L, Wang X. Xu B, et al. Among authors: tao j. Mol Cell Biochem. 2011 Apr;350(1-2):207-13. doi: 10.1007/s11010-010-0700-6. Epub 2011 Jan 1. Mol Cell Biochem. 2011. PMID: 21197560

9

Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells.

Wu D, Tao J, Xu B, Qing W, Li P, Lu Q, Zhang W. Wu D, et al. Among authors: tao j. Urol Int. 2011;86(3):346-54. doi: 10.1159/000322986. Epub 2011 Jan 27. Urol Int. 2011. PMID: 21273759

10

microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells.

Tao J, Lu Q, Wu D, Li P, Xu B, Qing W, Wang M, Zhang Z, Zhang W. Tao J, et al. Oncol Rep. 2011 Jun;25(6):1721-9. doi: 10.3892/or.2011.1245. Epub 2011 Apr 4. Oncol Rep. 2011. PMID: 21468550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,322 results

Search Page

Filters